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Pterygium, a wing-shaped degenerative fibrovascular 
growth of conjunctiva which encroaches onto the 
surface of the cornea, is common in the tropics.[1] It may 
be stable or grow progressively across the cornea to 
cover the visual axis. Pinguecula is also a degenerative 
growth occurring at the limbus but does not invade 
the cornea. Both pterygia and pingueculae occur in the 
interpalpebral fissure, more often nasally, occasionally 
temporally and less often, simultaneously nasal and 
temporal.[1] Actinic degeneration of the conjunctiva 
and cornea related to exposure to ultraviolet light and 
exacerbated by environmental factors such as wind 
and dust have been implicated in the pathogenesis 
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can also show isolated corneal involvement.[21] It has 
shown changing trends in its clinical presentation and 
progression with an upsurge of HIV infection which 
led to an increase in the incidence of OSSN. Thus, 
OSSN has been recognized to be strongly associated 
with HIV infection;[21] furthermore, HIV infection is 
now established as a risk factor for the development 
of squamous cell neoplasia of the conjunctiva based on 
studies from Rwanda, Malawi, and Uganda.[22,23] OSSN 
runs a more aggressive and invasive course in HIV 
patients requiring enucleation or even exenteration.[24] 
Conjunctival growth may also be a manifestation of 
systemic infections or malignancies such as Kaposi 
sarcoma and lymphomas.
This study examines the various conjunctival 
pathologies presenting to our unit over the past 
7 years, their management and outcome with the aim 
of evaluating the outcome of management and the need 
to modify management modalities or otherwise.
METHODOLOGY
The minor ophthalmic surgical database was 
retrospectively reviewed to obtain information on all 
patients who had conjunctival surgery from January 1, 
2008 to December 31, 2014. The information obtained 
included patients’ demographics, clinical features, 
preoperative diagnosis, associated ocular co‑morbidity, 
indications for surgery, type and date of surgery, 
type of anesthesia administered, and the outcome of 
management. The total number of minor ophthalmic 
surgeries within the study period was also computed. 
The data obtained were entered into Epi Info statistical 
software, version 3.4 (Epi Info™, Atlanta, Georgia, 
USA) and analyzed after the data entry was validated 
by double entry. Descriptive statistics was used to yield 
frequencies, percentages, and proportions. Analytical 
statistics was by Chi‑square test, and a P < 0.05 was 
considered statistically significant. The demographics 
of patients, the output and types of conjunctival 
surgeries performed were assessed. Ethical approval 
was obtained from the Institutional Medical Research 
Ethics Committee.
RESULTS
A total of 155 persons comprising 73 (47.1%) males 
and 82 (52.9%) females had conjunctival surgery 
within the study period [Figure 1], with an average 
age of 39.9 years (standard deviation [SD]: 15); age 
range (mean ± 2 SD) was 9.9–69.9 years, and the age 
group 31–40 years had the largest proportion of patients 
49 (31.6%). Furthermore, 32 persons (20.6%) had 
conjunctival surgeries in both eyes with a total of 187 eyes.
of pterygium. Prolonged exposure to these risk 
factors also causes corneal and conjunctival drying by 
disruption of the tear film.[2] Chronic irritation leads to 
a chronic inflammatory cell infiltration with edema, 
attempt at repair, and cell-induced angiogenesis. These 
processes are responsible for the fibrovascular reaction 
characteristic of a pterygium.[3] Other risk factors for 
pterygium include the use of traditional eye drops, 
exposure to chemical irritants, and a family history of 
pterygium.[4-6] Pterygium causes visual impairment by 
inducing significant corneal astigmatism or by actually 
invading the visual axis.[1] In Nigeria, 1% of moderate 
visual impairment and 0.5% of blindness are attributed 
to pterygium.[7] Various community‑based studies 
among adults revealed a prevalence of pterygium 
between 2.7% and 8.3%.[4,5,8-13] Hospital-based studies 
in South Western Nigeria revealed that pterygium 
accounted for 0.8% of cause of blindness among new 
patients[14] and was a cause of ocular morbidity in 6.4% 
of elderly patients in a primary eye care clinic[15] while 
in Northern Nigeria, pterygium accounted for 11% of 
cases of red eye in a tertiary eye care facility.[16] Akinsola 
et al. reported pterygium as the leading conjunctival 
mass presenting to their facility.[17] A survey of pediatric 
ophthalmic diagnosis in an eye care facility in Southern 
Nigeria showed that pterygium accounted for 1.06% of 
cases.[18]
The management of pterygium depends on the patient’s 
symptoms and the pterygium’s rate of progression. The 
primary indication for surgical removal of pterygia is 
a threat of or actual visual loss. Other indications for 
surgical removal include Chronic inflammation that 
is not responding to medical therapy and cosmetic 
blemish.[1] Potential complications of pterygium 
excision include recurrence which occasionally could 
be worse than the original disease.
Ocular surface squamous neoplasia (OSSN) is a 
broad term encompassing conjunctival intraepithelial 
neoplastic (CIN) lesions and invasive SCC of 
conjunctiva and cornea. The former (CIN) includes 
varying grades of dysplasia, ranging from mild, 
moderate, severe dysplasia to carcinoma in situ.[19] 
Factors that have been implicated in the development 
of OSSN include advanced age, male gender, exposure 
to solar ultraviolet radiation, infection with human 
papillomavirus, immunosuppression, and infection 
with human immunodeficiency virus (HIV).[19] Other 
oncogenic viruses like Kaposi sarcoma-associated 
herpes virus and Ebstein–Barr virus have been found 
in OSSN.[20] The disease entity “OSSN,” also known 
as an indolent disease of adult males, presents more 
commonly in the interpalpebral area of the perilimbal 
conjunctiva and can encroach on the cornea; OSSN 
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their histopathology reports ready. All had morbidity 
in one eye. Of these 12 eyes, SCC was the definitive 
diagnosis in 7 (58.3%) eyes, squamous cell papilloma in 
3 (25%) eyes, and junctional nevus and dermoid cysts 
in 1 (8.3%) eye each. The mean age of patients with SCC 
and squamous cell papilloma were 42.6 and 39 years, 
respectively. OSSN accounted for 83.3% of histological 
diagnosis of conjunctival neoplasia. No case of 
recurrence was observed among these eyes within the 
study period.
There were eight primary conjunctival morbidities 
[Table 1] and three other types of morbidity which 
were not primarily a conjunctival morbidity. The most 
common indication for surgery included pterygium in 
104 (55.6%) eyes and conjunctival mass in 51 (27.3%) 
eyes. However, 18 (9.6%) eyes had either an anterior 
segment or orbital morbidity that required conjunctival 
surgery.
A total of 584 minor ophthalmic surgeries were 
performed within the study period. Of these, 187 (32%) 
were conjunctival surgeries. Nine types of conjunctival 
surgeries were performed [Table 2]; pterygium excision 
104 (55.6%), excisional biopsy of other conjunctival 
growth 58 (31.0%), and conjunctival flap 14 (7.5%) were 
the most common conjunctival surgeries, 95.6% of these 
were performed under local anesthesia.
Eighty persons comprised of 36 (45%) males and 
44 (55%) females had pterygium excision. Their age 
was bimodally distributed with one peak at 31–40 years 
and another peak at 51–60 years [Figure 2]. Their mean 
age was 45.6 years (SD: 17); 86.2% of patients were 
aged >30 years while only 12.5% were aged >60 years. No 
patient was aged ≤20 years. There was an increase in the 
proportion of patients who had pterygium surgery with 
increasing age (2 = 19.6, P < 0.001). Pterygium excision 
was the most common conjunctival surgery within the 
study period with an annual average of 55.1% (2 = 8.4, 
P < 0.001). Of 104 eyes that had pterygium excision, only 
2 (1.9%) had the lesion on the temporal conjunctiva, the 
location was nasal in 102 (99.1%) eyes; 4 (3.8%) eyes had 
recurrent pterygia. Most pterygium excisions 91 (87.5%) 
were performed using the bare sclera technique, 
8 (7.7%) were combined with primary conjunctival 
autologous grafting, and 5 (4.8%) were performed with 
intraoperative application of mitomycin‑C to the sclera 
bed. Up to 31.6% of eyes (all operated by bare sclera 
technique) had recurrent pterygium.
Fourteen patients who had a biopsy of conjunctival mass 
had their case files reviewed, of these 12 patients had 
Figure 1: Age distribution of study population
Figure 2: Age distribution of patients who had pterygium
Table 1: Types and distribution of preoperative 
conjunctival morbidities
Conjunctival morbidity n (%)
Pterygium 104 (55.6)
Conjunctival mass 51 (27.3)
Conjunctival cyst 4 (2.1)
Pinguecula 2 (1.1)
Limbal dermoid cyst 2 (1.1)
Conjunctival nevus 2 (1.1)
Pseudopterygium 1 (0.5)
Conjunctival laceration 1 (0.5)
Conjunctival suture 1 (0.5)
Subconjunctival hemorrhage 1 (0.5)
Other (anterior segment and orbital 
diseases that required conjunctival surgery)
18 (9.6)
Total 187 (100)
Table 2: Types and distribution of conjunctival 
surgical procedures
Conjunctival surgical procedure n (%)
Pterygium excision 104 (55.6)
Excision biopsy 57 (31.0)
Conjunctival flap 15 (7.5)
Conjunctivectomy 5 (2.1)
Pinguecula excision 2 (1.1)
Conjunctival exploration and repair 1 (1.1)
Incision biopsy 1 (0.5)
Pseudopterygium excision 1 (0.5)
Conjunctival suture removal 1 (0.5)
Total 187 (100)
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Of 18 eyes that had conjunctival surgeries as a result 
of a nonconjunctival pathology, 14 (77.8%) were 
conjunctival flap surgeries, while 4 (22.2%) were 
conjunctivectomy for Mooren’s ulcer. Figure 3 shows 
the indications for conjunctival flap surgery in 14 eyes. 
Corneal ulcer/descemetocele and Mooren’s ulcer were 
the main indications for conjunctival flap surgeries 
observed in 5 (45.5%) and 3 (27.3%) eyes, respectively.
DISCUSSION
Conjunctival surgeries constituted about one‑third 
of minor ophthalmic surgical procedures within the 
study period. The observed mean age (39.9 years) of 
the study group is comparable to 42.9 years observed 
by Akinsola et al. in Lagos.[17]
Over half of conjunctival surgical morbidities were 
pterygia. This is not surprising as pterygium is 
common in tropical Africa. Proximity to the equator 
is a known risk factor. Our facility is located within 
latitude 80°22 N and 100°24 N and longitude 80°32 E 
and 100°24 E and has a near temperate climate with 
an average temperature between 18.7°C and 31.7°C. 
It serves as a referral center for the host state and five 
neighboring states with climatic conditions which favor 
the incidence of pterygia. Furthermore, farming (an 
outdoor occupation) is a major occupation in the region. 
The proportion of patients with pterygia (55.6%) 
observed in this study is comparable to 42% observed 
by Pola et al. in Zimbabwe[25] but contrasts to 89.5% 
reported by Akinsola et al. in Lagos.[17] This may be due 
to the fact that the Lagos study assessed preoperative 
conjunctival growth while our study assessed mainly 
surgical patients. Not all patients with pterygium had 
surgery. The mean age of patients who had pterygium 
excision (45.6 years) is comparable to 51.8 years and 
40 years observed by Fadamiro et al. in Ado-Ekiti, South 
Western Nigeria and Moukoury et al. in Cameroun, 
respectively.[26,27] We also observed that majority of 
these patients (86.2%) were aged over 30 years which 
is also comparable to findings in Cameroun where it 
was observed that 92% of the patients with pterygium 
were older than 30 years.[27] This is likely due to the 
effect of prolonged exposure to the established risk 
factors. However, in contrast to report by Adio et al. in 
Southern Nigeria,[18] there was no patient in the pediatric 
age group who had pterygium surgery in our study. 
Even though studies have shown that more males 
have a higher incidence and prevalence of pterygium 
compared to females,[28,29] we observed that more 
females (55%) had pterygium excision comparable to 
66.5% observed by Fadamiro et al. in South Western 
Nigeria.[26] This may be due to the fact that females 
are more conscious of cosmetic blemishes than their 
male counterparts, pterygium surgical services is also 
relatively affordable in the study center.
Only 1.9% of pterygia were located on the temporal 
conjunctiva, similar to 2.4% observed among Arabian 
patients with pterygia.[30] Surgery aims at removing 
the pterygium, restoring the conjunctival anatomy, 
and leaving the corneal surface as smooth and clear 
as possible. Numerous techniques are being used 
to achieve this goal. In this study, most (87.5%) 
pterygium surgeries were performed using the bare 
sclera technique. This technique is still in use by many 
surgeons worldwide in spite of the attendant high 
recurrence rate. The recurrence rate of 31.6% following 
excision by bare sclera technique observed in our 
study is close to 40% observed by Ashaye in Ibadan.[31] 
Conjunctival graft performed as a primary procedure 
with pterygium excision reduces the recurrence rate 
from upward of 70–80% to 5–15%.[1,27,32] Conjunctival 
autograft was introduced in our center in 2008 due to 
a high recurrence rate from the bare sclera technique. 
Intraoperative mitomycin-C application to the bare 
sclera bed after pterygium excision gives good results;[33] 
however, it has been associated with devastating 
ocular complications which include scleromalacia.[1] 
In the Lagos study, only 4.3% of eyes had pterygium 
excision with bare sclera technique while 95.7% had 
either pterygium excision with conjunctival autograft 
or with adjuvant therapy. Expectedly the overall 
rate of recurrence was low (13.2%).[17] The Lagos and 
Ado-Ekiti studies also revealed a low recurrence rate 
of 5% and 3.7% in eyes with conjunctival autograft, 
respectively.[17,26] Bekibele et al. reported a slightly 
lower recurrence rate with the use of five fluorouracil 
compared to conjunctival autograft.[34] Akinsola et al. 
reported a recurrence rate of 33.3% in eyes that were 
operated with bare sclera technique.[17] The latter is 
comparable to the recurrence rate observed in this 
study.
We observed that only 1.1% of eyes had pinguecula 
excision, which is quite low compared to 8.7% observed Figure 3: Indication for conjunctival flap surgery
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by Akinsola et al. in Lagos.[17] Again the different study 
groups (i.e., surgical versus clinic patients) could be 
responsible for this difference. Pinguecula, though a 
very common conjunctival morbidity, is not a common 
indication for surgery like pterygium. Indications 
for surgery will include recurrent inflammation and 
cosmesis.
Conjunctival neoplasia was the indication for surgery 
in a quarter of patients; this is higher than 0.5% 
observed by Akinsola et al. in Lagos[17] and lower than 
53% reported by Pola et al. in Zimababwe.[25] The higher 
prevalence of systemic illnesses like HIV/acquired 
immunodeficiency syndrome in Southern Africa may 
be the reason for the observed difference between 
our study and the study in Zimbabwe.[35] SCC of the 
conjunctiva was the most common (58.3%) OSSN 
in our study; this is similar to 56.6% observed by 
Ackuaku-Dogbe in Ghana.[36] The mean age of patients 
with OSSN (42.6 years) in our study is, however, in 
contrast to a mean age range of 32–37 years observed 
in Harare, Zimbabwe.[21,25] Other studies have reported 
OSSN as the first clinical presentation of HIV in young 
patients.[23,37] Late presentation and the fact that our 
patients were all surgical patients could be responsible 
for the observed difference.
Patients with a definitive diagnosis of squamous 
cell papilloma of the conjunctiva had a mean age of 
39.9 years, similar to the report of Ogun et al. in Ibadan 
where this neoplasm was found commonly in patients 
in their fourth decade of life.[38] It was the second 
most common type of OSSN observed in our study. 
Squamous cell papilloma is a benign neoplasm of the 
squamous epithelium of the conjunctiva characterized 
by finger-like projections comprised a fibrovascular 
core covered by acanthotic squamous epithelium.[39]
More patients had conjunctival cysts (2.1%) and limbal 
dermoid cysts (1.1%) in our study compared to 0.8% 
and 0.2% observed in Lagos, respectively,[17] but similar 
to 3.4% (conjunctival cysts) and 1.1% (limbal dermoid 
cysts) observed in Ghana.[36]
One eye (0.5%) each had conjunctival laceration and 
subconjunctival hemorrhage warranting surgical 
intervention. The conjunctiva can be easily affected 
in ocular trauma. Conjunctival lacerations must be 
carefully evaluated to ensure there is no underlying 
full thickness sclera laceration which may be obscured 
by significant subconjunctival hemorrhage.[1] Only one 
case of conjunctival laceration had to be sutured in 
theater in the period under review as most conjunctival 
lacerations are treated conservatively with topical 
antibiotics and occasionally pressure patching.
The main indications for conjunctival flap surgeries were 
corneal ulcer/descemetocele and Mooren’s ulcers that 
were associated with corneal perforation. Chronic corneal 
surface diseases are an important and common indication 
for conjunctival surgery.[1] Participants with perforated 
Mooren’s ulcers who had conjunctival flap surgery in 
this study were all relatively young (aged <40 years). 
Mooren’s ulcer is associated with autoimmune disease 
in some but not all patients. The West African type of 
ulcus rodens has a higher prevalence and a tendency 
toward perforation.[40] Conjunctival flap surgeries help 
to improve chronically compromised corneal surfaces. It 
is an effective method to replace damaged or nonexistent 
corneal epithelium with more resilient conjunctiva. The 
aim is to stabilize the eye, not to immediately improve 
vision. Conjunctivectomy is also a modality of treating 
Mooren’s ulcer.[41,42]
The hospital‑based nature of this study limits the 
inference which can be made on the types of conjunctival 
surgical morbidity in our environment. This will be 
better accomplished by a community-based study.
CONCLUSION
Conjunctival surgeries constituted about one‑third of 
minor ophthalmic surgeries in our center. Over half 
of conjunctival surgeries were pterygium excision 
mostly performed using the bare scleral method, 
with a significant recurrence rate; hence, the need 
for modification with the use of antimetabolites and 
conjunctival autograft. OSSN was the most common 
conjunctival neoplasia among patients with conjunctival 
surgeries in our setting.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
1. Spaeth GL. Ophthalmic Surgery: Principles and Practice. 3rd ed. 
Philadelphia: WB Saunders; 2003. p. 127‑34.
2. Balogun MM, Ashaye AO, Ajayi BG, Osuntokun OO. Tear break‑up 
time in eyes with pterygia and pingueculae in Ibadan. West Afr J Med 
2005;24:162‑6.
3. Hill JC, Maske R. Pathogenesis of pterygium. Eye (Lond) 
1989;3(Pt 2):218‑26.
4. Okoye OI, Umeh RE. Eye health of industrial workers in Southeastern 
Nigeria. West Afr J Med 2002;21:132‑7.
5. Omoti AE, Waziri‑Erameh JM, Enock ME. Ocular disorders in a 
petroleum industry in Nigeria. Eye (Lond) 2008;22:925‑9.
6. Anguria P, Ntuli S, Interewicz B, Carmichael T. Traditional eye 
medication and pterygium occurrence in Limpopo province. S Afr 
Med J 2012;102:687‑90.
Odugbo, et al.: Pattern and outcome of conjunctival surgeries
Nigerian Journal of  Ophthalmology / Jan‑Jun 2016 / Vol 24 / Issue 130
7. Abdull MM, Sivasubramaniam S, Murthy GV, Gilbert C, Abubakar T, 
Ezelum C, et al. Causes of blindness and visual impairment in 
Nigeria: The Nigeria national blindness and visual impairment survey. 
Invest Ophthalmol Vis Sci 2009;50:4114‑20.
8. Ajayi IA, Omotoye OJ. Pattern of eye diseases among welders in a 
Nigeria community. Afr Health Sci 2012;12:210‑6.
9. Bekibele CO, Ajav R, Asuzu MC. Eye health of professional drivers 
of a Nigerian University. Niger Postgrad Med J 2009;16:256‑9.
10. Wade PD, Odugbo OP, Velle LD, Kyari F. Prevalence and causes of 
ocular morbidity among commercial intercity vehicle drivers in Jos, 
Nigeria. Niger J Med 2011;52:123‑7.
11. Adekoya BJ, Owoeye JF, Adepoju FG, Ajaiyeoba AI. Pattern of eye 
diseases among commercial intercity vehicle drivers in Nigeria. Niger 
J Ophthalmol 2008;16:55‑9.
12. Oladehinde MK, Adeoye AO, Adegbehingbe BO, Onakoya AO. 
Visual functions of commercial drivers in relation to road accidents in 
Nigeria. Indian J Occup Environ Med 2007;11:71‑5.
13. Nwosu SN. Ocular problems of young adults in rural Nigeria. Int 
Ophthalmol 1998;22:259‑63.
14. Otulana TO. Blindness and visual impairment in Remo, Ogun State, 
Nigeria: A hospital‑based study. Niger Postgrad Med J 2012;19:153‑6.
15. Adebusoye LA, Owoaje ET, Ladipo MM, Adeniji AO. Visual morbidities 
among elderly patients presenting at a primary care clinic in Nigeria. 
West Afr J Med 2011;30:118‑20.
16. Lawan A. Causes of red eye in Aminu Kano Teaching Hospital, 
Kano‑Nigeria. Niger J Med 2009;18:184‑5.
17. Akinsola FB, Mbadugha CA, Onakoya AO, Adefule‑Ositelu AO, 
Aribaba OT, Rotimi‑Samuel A. Pattern of conjunctival masses seen at 
Guinness Eye Centre Luth Idi‑Araba. Nig Q J Hosp Med 2012;22:39‑43.
18. Adio AO, Alikor A, Awoyesuku E. Survey of pediatric ophthalmic 
diagnoses in a teaching hospital in Nigeria. Niger J Med 2011;20:105‑8.
19. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv 
Ophthalmol 1995;39:429‑50.
20. Simbiri KO, Murakami M, Feldman M, Steenhoff AP, Nkomazana O, 
Bisson G, et al. Multiple oncogenic viruses identified in ocular surface 
squamous neoplasia in HIV‑1 patients. Infect Agent Cancer 2010;5:6.
21. Karcioglu ZA, Wagoner MD. Demographics, etiology, and behavior 
of conjunctival squamous cell carcinoma in the 21st century. 
Ophthalmology 2009;116:2045‑6.
22. Thomas JO. Acquired immunodeficiency syndrome‑associated 
cancers in Sub‑Saharan Africa. Semin Oncol 2001;28:198‑206.
23. Spitzer MS, Batumba NH, Chirambo T, Bartz‑Schmidt KU, 
Kayange P, Kalua K, et al. Ocular surface squamous neoplasia 
as the first apparent manifestation of HIV infection in Malawi. Clin 
Experiment Ophthalmol 2008;36:422‑5.
24. Shields CL, Ramasubramanian A, Mellen PL, Shields JA. 
Conjunctival squamous cell carcinoma arising in immunosuppressed 
patients (organ transplant, human immunodeficiency virus infection). 
Ophthalmology 2011;118:2133‑7.
25. Pola EC, Masanganise R, Rusakaniko S. The trend of ocular 
surface squamous neoplasia among ocular surface tumour biopsies 
submitted for histology from Sekuru Kaguvi Eye Unit, Harare between 
1996 and 2000. Cent Afr J Med 2003;49:1‑4.
26. Fadamiro CO, Ajite KO, Ajayi AI, Omotoye OJ. Pterygium excision 
with conjunctival autograft: Our technique. Niger J Ophthalmol 
2012;20:38‑41.
27. Moukourv NE, Epee E, Nsangou JFI, Noa NTB. Pterygiun in a 
tropical region. Analysis of 344 cases in Cameroon. Bull Soc Belge 
Ophtalmol 2009 ;311:11‑5.
28. Wong TY, Foster PJ, Johnson GJ, Seah SK, Tan DT. The prevalence 
and risk factors for pterygium in an adult Chinese population 
in Singapore: The Tanjong Pagar survey. Am J Ophthalmol 
2001;131:176‑83.
29. McCarty CA, Fu CL, Taylor HR. Epidemiology of pterygium in Victoria, 
Australia. Br J Ophthalmol 2000;84:289‑92.
30. Dolezalová V. Is the occurrence of a temporal pterygium really so 
rare? Ophthalmologica 1977;174:88‑91.
31. Ashaye AO. Pterygium in Ibadan. West Afr J Med 1991;10:232‑43.
32. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft 
transplantation for advanced and recurrent pterygium. Ophthalmology 
1985;92:1461‑70.
33. Mpyet C, Oko H. Results of intra‑operative 0.5mg/ml mitomycin C 
with 20mg depo steroid in the treatment of primary pterygium. Cent 
Afr J Med 2000;46:330‑2.
34. Bekibele CO, Baiyeroju AM, Olusanya BA, Ashaye AO, Oluleye TS. 
Pterygium treatment using 5‑FU as adjuvant treatment compared to 
conjunctiva autograft. Eye (Lond) 2008;22:31‑4.
35. UNICEF. Prevalence of HIV in Zimbabwe. Available from: http://www.
unicef.org/infobycountry/Zimbabwe_statistics.html. [Last accessed 
on 2015 Jul 25].
36. Ackuaku‑Dogbe E. Histopathological features of tumours of the orbit 
and adnexia seen in Korle‑Bu teaching Hospital Ghana. West Afr J 
Med 2012;31:58‑62.
37. Pradeep TG, Gangasagara SB, Subbaramaiah GB, Suresh MB, 
Gangashettappa N, Durgappa R. Prevalence of undiagnosed HIV 
infection in patients with ocular surface squamous neoplasia in a 
tertiary center in Karnataka, South India. Cornea 2012;31:1282‑4.
38. Ogun OA, Ogun GO, Bekibele CO, Akang EE. Squamous papillomas 
of the conjunctiva: A retrospective clinicopathological study. Niger J 
Clin Pract 2012;15:89‑92.
39. Farah S, Baum TD, Conlon MR, Alfonso EC, Starck T, Albert D. 
Tumours of the cornea and conjunctiva. In: Albert DM, Jakobiec FA, 
editors. Principles and Practice of Ophthalmology. 2nd ed. 
Pennsylvania: W.B. Saunders; 2000. p. 1002‑19.
40. Stilma JS. Conjunctival excision or lamellar scleral autograft in 38 
Mooren’s ulcers from Sierra Leone. Br J Ophthalmol 1983;67:475‑8.
41. Chen J, Xie H, Wang Z, Yang B, Liu Z, Chen L, et al. Mooren’s 
ulcer in China: A study of clinical characteristics and treatment. Br J 
Ophthalmol 2000;84:1244‑9.
42. Nguyen QD. Mooren’s Ulcer: Diagnosis and Management. Available 
from: http//:www.uveitis.org/medical/articles/casez. [Last accessed 
on 2015 Jun 04].
